CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome? Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Association of Cardiovascular Disease With Respiratory Disease Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past? Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
|<<... 9 10 11 12 13 14 15 ...>>|

Clinical Trial2018 Apr 12;378(15):1386-1395.

JOURNAL：N Engl J Med. Article Link

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

Mehra MR, Goldstein DJ, MOMENTUM 3 Investigators. Keywords: Magnetically Levitated Left Ventricular Assist Device; heart failure; pump thrombosis;

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top